Bristol Myers reaches a crossroads as a make-or-break year takes shape
Bristol Myers Squibb is facing a bit of an identity crisis. CEO Chris Boerner is nearly two and a half years into his tenure, with most of his time defined by
Chris Boerner, Bristol Myers Squibb CEO (Kevin Dietsch/Getty Images) April 29, 2026 11:33 AM EDT R&DPharmaIn Focus Bristol Myers reaches a crossroads as a make-or-break year takes shape Max Gelman Senior Editor Bristol Myers Squibb is facing a bit of an identity crisis. CEO Chris Boerner is nearly two and a half years into his tenure, with … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that